Morgan Stanley Lowers Tesla Price Target to $400

1 min read Reproduced verbatim
Rating
Equalweight
Unchanged
Target
$400
from $417 (−4%)
Outcome
Reached
on October 27, 2026
Morgan Stanley and Tesla logos

What the analyst said

Morgan Stanley analyst Andrew Percoco lowered the price target on Tesla (NASDAQ: TSLA) to $400 (from $417) while maintaining an Equalweight rating.

“The capex step-up is a known trend, now confirmed and extended for the next 2-3 years, prolonging cash burn through the end of the decade on our estimates.

We view this as a necessary investment to establish and defend a leadership position in autonomy and robotics.

The open question remains the timing of when we actually see the ROI – specifically, a scaled robotaxi network that demonstrates increasing density and improving safety within existing cities, plus tangible progress commercializing Optimus.

Absent consistent, transparent proof points, we’d expect the market’s tolerance for incremental capex to narrow.

We are lowering our price target to $400 (from $417) reflecting increasing capex and worsening cash burn through the end of the decade. Our long-term estimates are broadly unchanged.

We assume lower gross margins in auto and energy carry through the remainder of the year, while continued R&D growth adds further margin pressure. In total, our 2026 adj.

EBITDA estimates decline by 7% with these changes.

This also carries forward to 2027 where we expect Energy margins to remain under pressure and R&D to continue to grow as Tesla further invests in Optimus, semi manufacturing, etc.

As a result, our 2027 adj. EBITDA estimate declines by 12%. The biggest change in our 2027 estimates is capex, where we now assume the company spends nearly $30bn (vs. $20bn previously).

Our higher capex and lower EBITDA estimates drives a FCF burn of ~$14bn in 2027 (vs. $5bn previously).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TSLA trades at $344. The 17 analysts who set a target in the last 3 months range from $24.86 to $500, with a median of $442. This $400 target is 10% below the median.

Since the note TSLA has moved −8% (from $374). 12-month window: day 105 of 365, closes on July 23, 2027.

Track record

This call✓ Target reached on October 27, 2026, 3 months after the note.

Firm track recordMorgan Stanley: 82% of its 49 targets at least a year old were reached within 12 months (#8 of 26 firms); on Tesla, 4 of 5. Accuracy ranking →

Earnings reactionOne of 14 notes after Tesla’s Jul 22 results: 0 raised · 10 cut · 2 kept. See every call →

Morgan Stanley on Tesla

Morgan Stanley price targets on Tesla

8 calls from February 10, 2026 to September 11, 2026. The target went from $415 to $400 (−4%). The rating stayed Hold.

Morgan Stanley targetTSLA share price
  1. September 11, 2026Kept the $400 targetHold$400
  2. September 2, 2026Kept the $400 targetHold$400
  3. July 23, 2026 This noteTarget cut from $417 (−4%)Hold$400
  4. July 14, 2026Target raised from $415 (0%)Hold$417
  5. July 6, 2026Kept the $415 targetHold$415
  6. April 23, 2026Kept the $415 targetHold$415
  7. April 20, 2026Kept the $415 targetHold$415
  8. February 10, 2026Earliest call shownHold$415
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.